Aducanumab (Aduhelm) Frequently Asked Questions
Resource Type:
Other
This resource is an FAQ about Aducanumab (Aduhelm) which is the newest drug for Alzheimer's disease. This medication may help slow progression of the early stage of Alzheimer's disease. This resource is intended to address questions from families, people living with dementia, and care professionals regarding the new FDA-approved Alzheimer's drug.
Link to Resource:
Subject:
Education & Learning
Collections:
Age-Friendly Care and Education Collection
Start the Conversation
Every registered user can comment on website content.
Please login or register to comment